BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy (Q97520951)
Jump to navigation
Jump to search
scientific article published on 08 July 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy |
scientific article published on 08 July 2020 |
Statements
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy (English)
Michael C McGee
8 July 2020
1 January 2021
4 references
13 July 2022
26 August 2022
22 October 2022
24 October 2022
5 references
13 July 2022
26 August 2022
22 October 2022
24 October 2022